Invene is an Inc. 5000 Honoree for Second Consecutive Year

‍

Invene, a leading healthcare-focused innovation and AI solutions firm, today announced it has earned its spot on the 2026 Inc. 5000 list of the fastest-growing private companies in America. This marks the company's second consecutive year on the prestigious list, which recognizes companies that have sustained exceptional growth in a competitive and fast-changing market.

‍

The Inc. 5000 list offers a comprehensive look at the most successful companies within America's independent, entrepreneurial business sector. Past honorees include Microsoft, Meta, Oracle, and Patagonia during their own high-growth years.

‍

Two Years Running, and Still Climbing

‍

Making the list once could be a fluke. Making it twice says something else. Invene's back-to-back recognition points to steady, growing demand from healthcare organizations that need outside expertise to actually ship AI and data initiatives, not just talk about them.

‍

Key growth drivers during the recognition period include:

‍

• Continued expansion across five healthcare segments, providers, payers, HealthTech companies, medical device manufacturers, and life sciences firms
• A year of proof for the acquisition of Guidea, with clinical UX and product strategy now running alongside engineering as one team instead of a bolt-on service
• Rising demand for GenAI implementation consulting, especially from PE-backed organizations whose boards want AI adoption on the roadmap now, not eventually
• More healthcare organizations turning to specialized partners as they prepare for 3-5 year exit strategies and need their technology story to hold up under diligence

‍

The recognition reflects the trust healthcare organizations continue to place in Invene's team to solve their most complex technology challenges, and it underscores just how much specialized expertise matters in an industry where the stakes are patient outcomes, not just uptime.

‍

Straight From the CEO

‍

James Griffin, Invene's CEO, shared his reaction to the news in a recent post, and his excitement was hard to miss.

‍

"Two years in a row we've made the Inc 5000," Griffin said. "Building a consulting company is a rollercoaster of ups and downs, so it's awesome to see Invene's growth recognized again among America's fastest-growing private companies."

‍

"Every year I get more excited for the future of Invene," he added. "As we scale, we continue to get more opportunities in healthcare to leverage data and AI to deliver outcomes for our clients. The most fun part is there's always something new to learn, and it's never the same day twice. Fingers crossed we'll keep up our growth trajectory to hit 3x next year."

‍

Addressing Complex Healthcare Technology Challenges

‍

Since its founding in 2018, Invene has built a reputation as the go-to partner for healthcare organizations that need technology solutions built to hold up under strict regulatory and compliance requirements. The team's expertise spans healthcare-specific frameworks like HL7, HIPAA, HITRUST, FHIR, and the newer wave of AI governance standards.

‍

What sets Invene apart isn't just its healthcare focus. It's what that focus buys clients, a team that already speaks the language of compliance, patient data, and clinical workflows, so nobody has to spend the first three months of a project explaining the basics. Rather than just building technology, Invene solves problems that directly affect patient care, operational efficiency, and growth in an industry where getting it wrong carries real consequences.

‍

The company's approach spans from strategic discovery and validation through full-scale application development and deployment, giving clients solutions that meet both technical requirements and regulatory standards. With Guidea's product strategy and UX expertise now fully woven into Invene's engineering capabilities, clients get one team handling everything from concept to deployment instead of juggling handoffs between vendors.

‍

Looking Ahead

‍

This recognition comes as healthcare organizations keep wrestling with AI implementation, particularly around use case prioritization, board communication, and building the internal muscle to adopt AI responsibly while staying compliant. Invene's clients need partners who understand both the technology and the regulatory reality they operate in, and that combination is exactly what's driving the company's continued growth.

‍

With Griffin eyeing 3x growth next year, Invene's momentum shows no sign of slowing as healthcare organizations continue to lean on specialized expertise to modernize their operations and prepare for whatever comes next.

‍

About the Inc. 5000 List

‍

The Inc. 5000 methodology ranks companies based on percentage revenue growth from 2022 to 2025. To qualify, companies must be U.S.-based, privately held, for-profit, and independent, with minimum revenue thresholds of $100,000 in 2022 and $2 million in 2025.

‍

This year's honorees added more than 627,208 jobs to the U.S. economy over the past three years, with the median three-year revenue growth rate across all 5,000 companies reaching 130 percent.

‍

About Invene

‍

Invene is a healthcare-focused innovation and AI solutions firm that transforms complex ideas into practical, impactful, and compliant technology solutions. Founded in 2018 by James Griffin with a 20-year vision to become the nation's leading healthcare consulting firm, the company operates with a fully remote, 100% USA-based team and specializes exclusively in healthcare.

‍

Invene's leadership team combines entrepreneurial vision, engineering expertise, and product design acumen, including CEO James Griffin (Forbes Next 1000 honoree), VP of Engineering Alex Melton, VP of Product Rebecca Loar, and VP of Strategic Accounts Adam Teitelman.

‍

For more information, contact us or book a strategy call.

‍

‍